• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有淋巴结转移的肝内胆管癌的手术治疗指征。

Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.

作者信息

Uenishi Takahiro, Kubo Shoji, Yamazaki Osamu, Yamada Terumasa, Sasaki Yo, Nagano Hiroaki, Monden Morito

机构信息

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.

出版信息

J Hepatobiliary Pancreat Surg. 2008;15(4):417-22. doi: 10.1007/s00534-007-1315-5. Epub 2008 Aug 1.

DOI:10.1007/s00534-007-1315-5
PMID:18670844
Abstract

BACKGROUND/PURPOSE: The postoperative outcome of patients who have intrahepatic cholangiocarcinoma with lymph node metastases is extremely poor, and the indications for surgery for such patients have yet to be clearly established.

METHODS

The demographic and clinical characteristics of 133 patients who underwent lymph node dissection during hepatic resection of intrahepatic cholangiocarcinoma were retrospectively analyzed.

RESULTS

Multivariate analysis identified three independent prognostic factors: intrahepatic metastasis, nodal involvement, and tumor at the margin of resection. Of the patients with tumor-free surgical margins, none of the 24 patients who had both lymph node metastases and intrahepatic metastases survived for 3 years. In contrast, the survival rates for the 23 patients who had lymph node metastases associated with a solitary tumor were 35% at 3 years and 26% at 5 years.

CONCLUSIONS

Surgery alone cannot prolong survival when both lymph node metastases and intrahepatic metastases are present, while surgery may provide a chance for long-term survival in some patients who have lymph node metastases associated with a solitary intrahepatic cholangiocarcinoma tumor.

摘要

背景/目的:肝内胆管癌伴淋巴结转移患者的术后预后极差,此类患者的手术指征尚未明确确立。

方法

回顾性分析133例行肝内胆管癌肝切除时行淋巴结清扫患者的人口统计学和临床特征。

结果

多因素分析确定了三个独立的预后因素:肝内转移、淋巴结受累及切缘肿瘤。在手术切缘无肿瘤的患者中,24例同时有淋巴结转移和肝内转移的患者无一人存活3年。相比之下,23例有孤立肿瘤伴淋巴结转移患者的3年生存率为35%,5年生存率为26%。

结论

当同时存在淋巴结转移和肝内转移时,单纯手术不能延长生存期,而手术可能为一些有孤立肝内胆管癌肿瘤伴淋巴结转移的患者提供长期生存的机会。

相似文献

1
Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.伴有淋巴结转移的肝内胆管癌的手术治疗指征。
J Hepatobiliary Pancreat Surg. 2008;15(4):417-22. doi: 10.1007/s00534-007-1315-5. Epub 2008 Aug 1.
2
Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.手术切缘状态对无淋巴结转移的孤立肿块型肝内胆管癌肝切除术的临床影响
J Surg Oncol. 2007 Aug 1;96(2):160-5. doi: 10.1002/jso.20792.
3
The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.肝内胆管细胞癌手术后的预后和生存结果:淋巴结转移和淋巴结清扫与生存的关系。
Ann Surg Oncol. 2009 Nov;16(11):3048-56. doi: 10.1245/s10434-009-0631-1. Epub 2009 Jul 22.
4
Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.肝切除术后肝内胆管癌的预后因素:单因素和多因素分析
Hepatogastroenterology. 2002 Mar-Apr;49(44):311-6.
5
Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.淋巴结转移及手术切缘状态对远端胆管癌的预后意义
J Surg Oncol. 2007 Mar 1;95(3):207-12. doi: 10.1002/jso.20668.
6
Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.肿块型肝内胆管癌TNM分期中的浆膜侵犯
J Hepatobiliary Pancreat Surg. 2005;12(6):479-83. doi: 10.1007/s00534-005-1026-8.
7
Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.对于晚期肝内胆管癌患者可考虑行肝胰十二指肠切除术。
Hepatogastroenterology. 2007 Mar;54(74):346-9.
8
Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.肝内胆管癌的长期预后及预后因素。
Chin Med J (Engl). 2009 Oct 5;122(19):2286-91.
9
Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.肝内胆管癌切除术后长期生存患者的临床病理特征
Hepatogastroenterology. 2003 Jul-Aug;50(52):1069-72.
10
Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement.肝内胆管细胞癌淋巴结无转移患者肝切除术中淋巴结清扫的治疗价值
Surgery. 2009 Apr;145(4):411-6. doi: 10.1016/j.surg.2008.11.010. Epub 2009 Feb 23.

引用本文的文献

1
Incidence trend and prognosis of intrahepatic cholangiocarcinoma: a study based on the SEER database.肝内胆管癌的发病率趋势及预后:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Transl Cancer Res. 2023 Nov 30;12(11):3007-3015. doi: 10.21037/tcr-23-1278. Epub 2023 Oct 26.
2
Lymph Node Dissection in Intrahepatic Cholangiocarcinoma: a Critical and Updated Review of the Literature.肝内胆管癌淋巴结清扫:文献综述的关键和最新回顾。
J Gastrointest Surg. 2023 Dec;27(12):3001-3013. doi: 10.1007/s11605-023-05696-8. Epub 2023 Aug 7.
3
Survival Benefit of Surgical Treatment for Elderly Patients with Intrahepatic Cholangiocarcinoma: A Retrospective Cohort Study in the SEER Database by Propensity Score Matching Analysis.
手术治疗老年肝内胆管细胞癌患者的生存获益:SEER 数据库倾向评分匹配分析的回顾性队列研究。
Curr Oncol. 2023 Feb 22;30(3):2642-2652. doi: 10.3390/curroncol30030201.
4
The Oncologic Implications of Tumor Multiplicity in Intrahepatic Cholangiocarcinoma: Its Prognostic Value Might Be Underestimated.肝内胆管细胞癌肿瘤多发性的肿瘤学意义:其预后价值可能被低估。
Cancer Res Treat. 2023 Jul;55(3):948-955. doi: 10.4143/crt.2023.290. Epub 2023 Feb 27.
5
Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.日本肝癌研究组肝内胆管癌临床实践指南
Liver Cancer. 2022 Feb 23;11(4):290-314. doi: 10.1159/000522403. eCollection 2022 Jul.
6
Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts.复发性肝内胆管癌患者的进展模式及进展后生存情况:基于多中心队列的新型预后列线图
Front Oncol. 2022 Apr 8;12:832038. doi: 10.3389/fonc.2022.832038. eCollection 2022.
7
Surgical management of biliary malignancy.胆管恶性肿瘤的外科治疗
Curr Probl Surg. 2021 Feb;58(2):100854. doi: 10.1016/j.cpsurg.2020.100854. Epub 2020 Jun 30.
8
Histological classification of microvascular invasion to predict prognosis in intrahepatic cholangiocarcinoma.微血管侵犯的组织学分类以预测肝内胆管癌的预后
Int J Clin Exp Pathol. 2017 Jul 1;10(7):7674-7681. eCollection 2017.
9
The role of ALPPS in intrahepatic cholangiocarcinoma.联合肝脏离断和门静脉结扎的二步肝切除术(ALPPS)在肝内胆管细胞癌中的作用。
Langenbecks Arch Surg. 2019 Nov;404(7):885-894. doi: 10.1007/s00423-019-01838-2. Epub 2019 Nov 16.
10
Diagnostic-therapeutic management of bile duct cancer.胆管癌的诊断与治疗管理
World J Clin Cases. 2019 Jul 26;7(14):1732-1752. doi: 10.12998/wjcc.v7.i14.1732.